Effects of stimulators and inhibitors on arachidonic acid metabolism in hepatoma.
D000818:Animals; D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000378:metabolism*; D001241:Aspirin / Q000494:pharmacology; D002084:Butylated Hydroxytoluene / Q000031:analogs & derivatives / Q000494:pharmacology; D006528:Carcinoma, Hepatocellular / Q000378:metabolism*; D007213:Indomethacin / Q000494:pharmacology; D008113:Liver Neoplasms; D011453:Prostaglandins / Q000096:biosynthesis*; D051381:Rats; D012980:Sodium Salicylate / Q000494:pharmacology; D013929:Thromboxane B2 / Q000096:biosynthesis*; D013931:Thromboxanes / Q000096:biosynthesis*; D014364:Tryptophan / Q000494:pharmacology
D001095:Arachidonic Acids; D011453:Prostaglandins; D013931:Thromboxanes; D002084:Butylated Hydroxytoluene; D016718:Arachidonic Acid; D013929:Thromboxane B2; C013753:2-aminomethyl-4-t-butyl-6-iodophenol; D014364:Tryptophan; D001241:Aspirin; D012980:Sodium Salicylate; D007213:Indomethacin